MedTrace Logo

Jewel ACL Post Market Clinical Follow Up Study

NCT04580290 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-11-02

Study results available
· View outcomes & findings →

Summary

The objective of the study is to assess re-rupture rates and patient outcomes from subjects with at least 5 year follow up, treated with the JewelACL device for ACL reconstruction. The impact of fixation type and autograft augmentation will also be assessed. All adverse events related to the JewelACL device will be recorded. This study is Sponsored by Xiros.

Conditions

  • Anterior Cruciate Ligament Injuries

Interventions

DEVICE

JewelACL

The JewelACL is a polyester scaffold for anterior cruciate ligament (ACL) reconstruction

Sponsors & Collaborators

  • Xiros Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-02
Primary Completion
2021-04-09
Completion
2021-04-09

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04580290 on ClinicalTrials.gov